In their article entitled “Cognitive issues in patients with IDH mutant gliomas: from neuroscience to clinical neuropsychology“, Michael Parsons and David Sabeseitz summarize the current understanding of cognitive symptoms in patients with IDH-Mutant gliomas [16]. Here, IDH1 is linked to central nervous system cancer.